Email not displaying properly? View email in your browser

Drug development  Auto-injector  Drug Regimens Jan 2017 e-Newsletter Archives    |    Advertise News Lilly and CoLucid Pharmaceuticals Announce Agreement... Biocon Ltd Wins MYR 300 Million Contract for for Insulin from... Evotec Enters into an Integrated Drug Discovery Collaboration...   Press Releases Flex Pharma Focuses on Phase 2 Clinical Programs in Severe Neurological... ViraCyte Receives Orphan Drug Designation for... Onxeo Completes Enrollment in Phase III Study of Livatag...   Events 01 - 02 Feb 2017 Pharmapack Europe 2017 01 -02 Feb 2017 Advanced Analytics for Clinical Data 2017 14 -16 Feb 2017 Biologistics World Asia 2017 Articles  The Future of Pharma Regulations YogiRaj, Associate Vice President, Freyr Solutions, India  Drug development Rajendra Talele, Head of Clinical Development Services Accutest Research Laboratories Pvt Ltd, India Techno Trends  Aptar Pharma and Medtech firms to Develop Novel Auto-injector  Heptares Therapeutics and Kymab Limited to Develop Novel Antibody... Projects  GE Plans to Invest US$156 Million in a Biopharmaceutical Manufacturing Campus in Cork, Ireland  Phillips-Medisize Plans to Open New 80, 000 square foot Manufacturing Facility in Menomonie, WI Research Insight  Priority-Setting for Novel Drug Regimens to Treat Tuberculosis... e-Magazine  |  Subscribe  |  Unsubscribe  |  Previous Issues  |  Advisory Board  |  Editorial Calendar  |  Media Pack www.pharmafocusasia.com – Owned by Ochre Media Pvt. Ltd. Media Resource Centre, 2nd Floor, Oxford Plaza, Secunderabad - 500 003, Telangana, India Tel: +91 40 4961 4567 I Fax: +91 40 4961 4555